Development of human recombinant decorin core protein as an anti-scarring therapeutic for dystrophic epidermolysis bullosa
Ended Project Grant Awarded Last action
- Award ID
- W81XWH1910834
- Recipient
-
Kamal Therapeutics, Inc. UEI PEB8K1DDELY5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $2,991,032
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Originally
- Place of performance
- Hingham, MA 02043, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $2,991,032 |
Quick answers
Who received award W81XWH1910834?
W81XWH1910834 was awarded to Kamal Therapeutics, Inc. by Defense Health Agency (Department of Defense) on September 30, 2019.
How much is award W81XWH1910834 worth?
$2,991,032 has been obligated on W81XWH1910834.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award